Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Neu-P11 in Subjects With Primary Insomnia [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety, tolerability, pharmacokinetics and pharmacodynamics of Neu-P11 in adults with primary insomnia; the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Neu-P11

Snippet

Sponsor: Neurim Pharmaceuticals Ltd. | Conditions: Insomnia | Phase 1 | Status: COMPLETED